Citus improves skin monitoring by mechanical characterization and provides a range of services.
Citus has raised $412K in total funding. The most recent round was Convertible Note. The last funding was announced in October 2023.
Citus's investors include S2S Ventures, Evoleen AG, University Hospital Zurich, CADFEM.
Citus is headquartered in Dubendorf, Switzerland.
Citus improves skin monitoring by mechanical characterization and provides a range of services.
Citus is at the Convertible Note stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Citus — Funding & Investors." VCBacked, October 6, 2023, https://www.vcbacked.co/company/citus. Accessed November 14, 2026.
VCBacked. (2023). Citus — Funding & Investors. Retrieved November 14, 2026, from https://www.vcbacked.co/company/citus
{{cite web |title=Citus — Funding & Investors |url=https://www.vcbacked.co/company/citus |website=VCBacked |access-date=November 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Citus? Request a listing update